Pulmonary & Respiratory Medicine

Qinfu Feng

Publications

• Research Article
  Long-Term Outcomes of Recurrent Thymoma
  Author(s): Cai Xu, Qinfu Feng, Zhouguang Hui, Chengcheng Fan, Yirui Zhai, Yidong Chen, Hongxing Zhang, Zefen Xiao, Jun Liang, Dongfu Chen, Zongmei Zhou, Miaoli Zheng, Xiaodan Wang, Lvhua Wang and Jie HeCai Xu, Qinfu Feng, Zhouguang Hui, Chengcheng Fan, Yirui Zhai, Yidong Chen, Hongxing Zhang, Zefen Xiao, Jun Liang, Dongfu Chen, Zongmei Zhou, Miaoli Zheng, Xiaodan Wang, Lvhua Wang and Jie He
  
  Background: This study sought to analyze the results and prognosis of recurrent thymoma. Methods: Between 1991 and 2012, 32 patients that developed recurring thymoma after radical resection at initial treatment were reviewed. Results: The median follow-up duration after initial treatment and recurrence was 89 and 49.5 months, respectively. The median recurrence free internal (RFI) was 42 months, and the 5-year overall survival (OS) rates following recurrence was 65.5% for recurrent thymoma. Among 32 patients that relapsed, 7 underwent reoperation, 18 experienced nonsurgical management, 5 failed to receive treatment, and 2 remain unknown. The 5-year OS rates after recurrence of the surgery plus adjuvant chemotherapy/radiotherapy group and the non-surgery group were 100% and 73.1%, respectively (P=0.210). Histological WHO upgrading was frequently observed (57.1%) in pat.. Read More»
  DOI: 10.4172/2161-105X.1000367

  Abstract PDF